STOCK TITAN

[8-K] Preformed Line Products Co Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Amendment No. 2 to Schedule 13D reports the current holdings of Bradley L. Radoff and the Radoff Family Foundation in Identiv, Inc. (INVE) common stock as of 10 Jul 2025.

  • Ownership: Mr. Radoff directly controls 1,805,000 shares; the Foundation holds 266,049 shares. Together they beneficially own 2,071,049 shares, equal to 8.8 % of the 23,617,379 shares outstanding (per Identiv’s 10-Q dated 9 May 2025).
  • Cost basis: Foundation purchases total ≈ $0.94 million; Mr. Radoff’s purchases total ≈ $6.14 million. Funds came from working or personal capital and may include customary margin loans.
  • Voting & dispositive power: Mr. Radoff has sole voting/dispositive power over his 1.805 million shares and shared power over the Foundation’s 266 k shares; the Foundation itself has shared voting/dispositive power over its stake.
  • Exhibit 2: Lists open-market transactions since Amendment No. 1 (details not included in the text).

The filing supplies updated share counts but does not outline any new strategic, operational, or governance intentions. It primarily confirms that the Radoff entities remain significant minority shareholders.

L'Emendamento n. 2 al Schedule 13D riporta le partecipazioni attuali di Bradley L. Radoff e della Radoff Family Foundation nelle azioni ordinarie di Identiv, Inc. (INVE) al 10 luglio 2025.

  • Proprietà: Il Sig. Radoff controlla direttamente 1.805.000 azioni; la Fondazione detiene 266.049 azioni. Insieme possiedono beneficiariamente 2.071.049 azioni, pari al 8,8% delle 23.617.379 azioni in circolazione (secondo il 10-Q di Identiv datato 9 maggio 2025).
  • Base di costo: Gli acquisti della Fondazione ammontano a circa 0,94 milioni di dollari; quelli del Sig. Radoff a circa 6,14 milioni di dollari. I fondi provengono da capitale operativo o personale e possono includere prestiti a margine consueti.
  • Potere di voto e dispositivi: Il Sig. Radoff detiene il potere esclusivo di voto e dispositivi sulle sue 1,805 milioni di azioni e potere condiviso su 266 mila azioni della Fondazione; la Fondazione stessa ha potere condiviso di voto e dispositivi sulla propria partecipazione.
  • Allegato 2: Elenca le transazioni sul mercato aperto dalla presentazione dell'Emendamento n. 1 (dettagli non inclusi nel testo).

La documentazione fornisce aggiornamenti sul numero di azioni detenute ma non indica nuove intenzioni strategiche, operative o di governance. Conferma principalmente che le entità Radoff rimangono azionisti di minoranza significativi.

La Enmienda n.º 2 al Schedule 13D informa sobre las participaciones actuales de Bradley L. Radoff y la Radoff Family Foundation en acciones comunes de Identiv, Inc. (INVE) al 10 de julio de 2025.

  • Propiedad: El Sr. Radoff controla directamente 1.805.000 acciones; la Fundación posee 266.049 acciones. En conjunto poseen de forma beneficiaria 2.071.049 acciones, equivalentes al 8,8 % de las 23.617.379 acciones en circulación (según el 10-Q de Identiv fechado el 9 de mayo de 2025).
  • Base de costo: Las compras de la Fundación suman aproximadamente 0,94 millones de dólares; las del Sr. Radoff, aproximadamente 6,14 millones. Los fondos provinieron de capital operativo o personal e incluyen posibles préstamos con margen habituales.
  • Poder de voto y dispositivo: El Sr. Radoff tiene poder exclusivo de voto y disposición sobre sus 1,805 millones de acciones y poder compartido sobre las 266 mil acciones de la Fundación; la Fundación tiene poder compartido de voto y disposición sobre su participación.
  • Anexo 2: Lista las transacciones en mercado abierto desde la Enmienda n.º 1 (detalles no incluidos en el texto).

El documento proporciona cifras actualizadas de acciones pero no detalla nuevas intenciones estratégicas, operativas o de gobernanza. Principalmente confirma que las entidades Radoff siguen siendo accionistas minoritarios significativos.

Schedule 13D의 수정안 2호는 2025년 7월 10일 기준으로 Bradley L. Radoff와 Radoff Family Foundation이 Identiv, Inc.(INVE)의 보통주를 보유한 현황을 보고합니다.

  • 소유권: Radoff 씨는 직접 1,805,000주를 보유하고 있으며, 재단은 266,049주를 보유하고 있습니다. 두 기관이 합쳐서 2,071,049주를 실질적으로 소유하고 있으며, 이는 총 23,617,379주(2025년 5월 9일자 Identiv 10-Q 보고서 기준)의 8.8%에 해당합니다.
  • 취득원가: 재단의 구매액은 약 94만 달러, Radoff 씨의 구매액은 약 614만 달러입니다. 자금은 운영자본 또는 개인 자본에서 나왔으며, 일반적인 마진 대출이 포함될 수 있습니다.
  • 의결권 및 처분권: Radoff 씨는 자신의 180만 5천 주에 대해 단독 의결권 및 처분권을 가지고 있으며, 재단의 26만 6천 주에 대해서는 공동 권한을 가지고 있습니다. 재단 역시 보유 지분에 대해 공동 의결권 및 처분권을 가지고 있습니다.
  • 첨부문서 2: 수정안 1호 이후의 장외거래 내역을 나열하고 있습니다(세부사항은 본문에 포함되지 않음).

이 제출 문서는 보유 주식 수를 업데이트하지만 새로운 전략적, 운영적 또는 거버넌스 의도는 명시하지 않습니다. 주로 Radoff 관련 기관들이 여전히 중요한 소수 주주임을 확인하는 내용입니다.

L'amendement n° 2 au Schedule 13D rapporte les participations actuelles de Bradley L. Radoff et de la Radoff Family Foundation dans les actions ordinaires d'Identiv, Inc. (INVE) au 10 juillet 2025.

  • Propriété : M. Radoff contrôle directement 1 805 000 actions ; la Fondation détient 266 049 actions. Ensemble, ils possèdent bénéficiairement 2 071 049 actions, soit 8,8 % des 23 617 379 actions en circulation (selon le 10-Q d'Identiv daté du 9 mai 2025).
  • Base de coût : Les achats de la Fondation totalisent environ 0,94 million de dollars ; ceux de M. Radoff environ 6,14 millions. Les fonds proviennent de capitaux opérationnels ou personnels et peuvent inclure des prêts sur marge habituels.
  • Pouvoir de vote et de disposition : M. Radoff détient le pouvoir exclusif de vote et de disposition sur ses 1,805 million d’actions et un pouvoir partagé sur les 266 000 actions de la Fondation ; la Fondation elle-même dispose d’un pouvoir partagé de vote et de disposition sur sa participation.
  • Exhibit 2 : Liste les transactions sur le marché libre depuis l’amendement n° 1 (détails non inclus dans le texte).

Le dépôt fournit des mises à jour sur le nombre d’actions détenues mais ne précise aucune nouvelle intention stratégique, opérationnelle ou de gouvernance. Il confirme principalement que les entités Radoff restent des actionnaires minoritaires importants.

Nachtrag Nr. 2 zum Schedule 13D berichtet über die aktuellen Beteiligungen von Bradley L. Radoff und der Radoff Family Foundation an den Stammaktien von Identiv, Inc. (INVE) zum 10. Juli 2025.

  • Eigentum: Herr Radoff kontrolliert direkt 1.805.000 Aktien; die Stiftung hält 266.049 Aktien. Zusammen besitzen sie wirtschaftlich 2.071.049 Aktien, was 8,8 % der 23.617.379 ausstehenden Aktien entspricht (laut Identivs 10-Q vom 9. Mai 2025).
  • Kostenbasis: Die Käufe der Stiftung belaufen sich auf ca. 0,94 Millionen US-Dollar; die Käufe von Herrn Radoff auf ca. 6,14 Millionen US-Dollar. Die Mittel stammen aus Betriebs- oder Privatkapital und können übliche Margin-Darlehen einschließen.
  • Stimm- und Verfügungsrecht: Herr Radoff hat das alleinige Stimm- und Verfügungsrecht über seine 1,805 Millionen Aktien und ein gemeinsames Recht über die 266.000 Aktien der Stiftung; die Stiftung selbst hat ein gemeinsames Stimm- und Verfügungsrecht über ihren Anteil.
  • Anlage 2: Listet die Transaktionen am offenen Markt seit Nachtrag Nr. 1 auf (Details nicht im Text enthalten).

Die Einreichung liefert aktualisierte Aktienzahlen, benennt jedoch keine neuen strategischen, operativen oder Governance-Absichten. Sie bestätigt hauptsächlich, dass die Radoff-Einheiten weiterhin bedeutende Minderheitsaktionäre sind.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: 8.8 % stake reaffirmed; informational filing, no new activism disclosed—neutral near-term impact.

The amendment refreshes Bradley L. Radoff’s and his foundation’s ownership in Identiv. At 8.8 %, the stake remains above the 5 % activist threshold, keeping Radoff on the list of influential outside holders. However, because the document contains no proposals, board nominations, or strategic language, it serves chiefly as a compliance update. Funding sources (personal and working capital, possibly margin) raise no immediate liquidity concerns. Investors may view the sustained position as a vote of confidence, yet the absence of forward intentions tempers any bullish interpretation. Overall, the disclosure is material for cap-table accuracy but unlikely to move the stock on its own.

L'Emendamento n. 2 al Schedule 13D riporta le partecipazioni attuali di Bradley L. Radoff e della Radoff Family Foundation nelle azioni ordinarie di Identiv, Inc. (INVE) al 10 luglio 2025.

  • Proprietà: Il Sig. Radoff controlla direttamente 1.805.000 azioni; la Fondazione detiene 266.049 azioni. Insieme possiedono beneficiariamente 2.071.049 azioni, pari al 8,8% delle 23.617.379 azioni in circolazione (secondo il 10-Q di Identiv datato 9 maggio 2025).
  • Base di costo: Gli acquisti della Fondazione ammontano a circa 0,94 milioni di dollari; quelli del Sig. Radoff a circa 6,14 milioni di dollari. I fondi provengono da capitale operativo o personale e possono includere prestiti a margine consueti.
  • Potere di voto e dispositivi: Il Sig. Radoff detiene il potere esclusivo di voto e dispositivi sulle sue 1,805 milioni di azioni e potere condiviso su 266 mila azioni della Fondazione; la Fondazione stessa ha potere condiviso di voto e dispositivi sulla propria partecipazione.
  • Allegato 2: Elenca le transazioni sul mercato aperto dalla presentazione dell'Emendamento n. 1 (dettagli non inclusi nel testo).

La documentazione fornisce aggiornamenti sul numero di azioni detenute ma non indica nuove intenzioni strategiche, operative o di governance. Conferma principalmente che le entità Radoff rimangono azionisti di minoranza significativi.

La Enmienda n.º 2 al Schedule 13D informa sobre las participaciones actuales de Bradley L. Radoff y la Radoff Family Foundation en acciones comunes de Identiv, Inc. (INVE) al 10 de julio de 2025.

  • Propiedad: El Sr. Radoff controla directamente 1.805.000 acciones; la Fundación posee 266.049 acciones. En conjunto poseen de forma beneficiaria 2.071.049 acciones, equivalentes al 8,8 % de las 23.617.379 acciones en circulación (según el 10-Q de Identiv fechado el 9 de mayo de 2025).
  • Base de costo: Las compras de la Fundación suman aproximadamente 0,94 millones de dólares; las del Sr. Radoff, aproximadamente 6,14 millones. Los fondos provinieron de capital operativo o personal e incluyen posibles préstamos con margen habituales.
  • Poder de voto y dispositivo: El Sr. Radoff tiene poder exclusivo de voto y disposición sobre sus 1,805 millones de acciones y poder compartido sobre las 266 mil acciones de la Fundación; la Fundación tiene poder compartido de voto y disposición sobre su participación.
  • Anexo 2: Lista las transacciones en mercado abierto desde la Enmienda n.º 1 (detalles no incluidos en el texto).

El documento proporciona cifras actualizadas de acciones pero no detalla nuevas intenciones estratégicas, operativas o de gobernanza. Principalmente confirma que las entidades Radoff siguen siendo accionistas minoritarios significativos.

Schedule 13D의 수정안 2호는 2025년 7월 10일 기준으로 Bradley L. Radoff와 Radoff Family Foundation이 Identiv, Inc.(INVE)의 보통주를 보유한 현황을 보고합니다.

  • 소유권: Radoff 씨는 직접 1,805,000주를 보유하고 있으며, 재단은 266,049주를 보유하고 있습니다. 두 기관이 합쳐서 2,071,049주를 실질적으로 소유하고 있으며, 이는 총 23,617,379주(2025년 5월 9일자 Identiv 10-Q 보고서 기준)의 8.8%에 해당합니다.
  • 취득원가: 재단의 구매액은 약 94만 달러, Radoff 씨의 구매액은 약 614만 달러입니다. 자금은 운영자본 또는 개인 자본에서 나왔으며, 일반적인 마진 대출이 포함될 수 있습니다.
  • 의결권 및 처분권: Radoff 씨는 자신의 180만 5천 주에 대해 단독 의결권 및 처분권을 가지고 있으며, 재단의 26만 6천 주에 대해서는 공동 권한을 가지고 있습니다. 재단 역시 보유 지분에 대해 공동 의결권 및 처분권을 가지고 있습니다.
  • 첨부문서 2: 수정안 1호 이후의 장외거래 내역을 나열하고 있습니다(세부사항은 본문에 포함되지 않음).

이 제출 문서는 보유 주식 수를 업데이트하지만 새로운 전략적, 운영적 또는 거버넌스 의도는 명시하지 않습니다. 주로 Radoff 관련 기관들이 여전히 중요한 소수 주주임을 확인하는 내용입니다.

L'amendement n° 2 au Schedule 13D rapporte les participations actuelles de Bradley L. Radoff et de la Radoff Family Foundation dans les actions ordinaires d'Identiv, Inc. (INVE) au 10 juillet 2025.

  • Propriété : M. Radoff contrôle directement 1 805 000 actions ; la Fondation détient 266 049 actions. Ensemble, ils possèdent bénéficiairement 2 071 049 actions, soit 8,8 % des 23 617 379 actions en circulation (selon le 10-Q d'Identiv daté du 9 mai 2025).
  • Base de coût : Les achats de la Fondation totalisent environ 0,94 million de dollars ; ceux de M. Radoff environ 6,14 millions. Les fonds proviennent de capitaux opérationnels ou personnels et peuvent inclure des prêts sur marge habituels.
  • Pouvoir de vote et de disposition : M. Radoff détient le pouvoir exclusif de vote et de disposition sur ses 1,805 million d’actions et un pouvoir partagé sur les 266 000 actions de la Fondation ; la Fondation elle-même dispose d’un pouvoir partagé de vote et de disposition sur sa participation.
  • Exhibit 2 : Liste les transactions sur le marché libre depuis l’amendement n° 1 (détails non inclus dans le texte).

Le dépôt fournit des mises à jour sur le nombre d’actions détenues mais ne précise aucune nouvelle intention stratégique, opérationnelle ou de gouvernance. Il confirme principalement que les entités Radoff restent des actionnaires minoritaires importants.

Nachtrag Nr. 2 zum Schedule 13D berichtet über die aktuellen Beteiligungen von Bradley L. Radoff und der Radoff Family Foundation an den Stammaktien von Identiv, Inc. (INVE) zum 10. Juli 2025.

  • Eigentum: Herr Radoff kontrolliert direkt 1.805.000 Aktien; die Stiftung hält 266.049 Aktien. Zusammen besitzen sie wirtschaftlich 2.071.049 Aktien, was 8,8 % der 23.617.379 ausstehenden Aktien entspricht (laut Identivs 10-Q vom 9. Mai 2025).
  • Kostenbasis: Die Käufe der Stiftung belaufen sich auf ca. 0,94 Millionen US-Dollar; die Käufe von Herrn Radoff auf ca. 6,14 Millionen US-Dollar. Die Mittel stammen aus Betriebs- oder Privatkapital und können übliche Margin-Darlehen einschließen.
  • Stimm- und Verfügungsrecht: Herr Radoff hat das alleinige Stimm- und Verfügungsrecht über seine 1,805 Millionen Aktien und ein gemeinsames Recht über die 266.000 Aktien der Stiftung; die Stiftung selbst hat ein gemeinsames Stimm- und Verfügungsrecht über ihren Anteil.
  • Anlage 2: Listet die Transaktionen am offenen Markt seit Nachtrag Nr. 1 auf (Details nicht im Text enthalten).

Die Einreichung liefert aktualisierte Aktienzahlen, benennt jedoch keine neuen strategischen, operativen oder Governance-Absichten. Sie bestätigt hauptsächlich, dass die Radoff-Einheiten weiterhin bedeutende Minderheitsaktionäre sind.

false000008003500000800352025-07-162025-07-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________
FORM 8-K
_________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 16, 2025
_________________________________________________________
Preformed Line Products Company
(Exact name of Registrant as Specified in Its Charter)
_________________________________________________________
Ohio0-3116434-0676895
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
660 Beta Drive
Mayfield Village, Ohio
44143
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: 440 461-5200
(Former Name or Former Address, if Changed Since Last Report)
_________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
CommonPLPCThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 1.01 Entry into a Material Definitive Agreement
On July 16, 2025, PLP Poland (Belos) S.A. ("PLP Poland"), a subsidiary of Preformed Line Products Company (the “Company”), entered into a non-revolving investment loan with Bank Polska Kasa Opieki Spółka Akcyjna ("Bank Pekao S.A.") to finance the construction of a new manufacturing plant. The loan is guaranteed by the Company and secured by the current manufacturing plant owned by PLP Poland, the plant under construction and all fixed assets within both plants.
The loan allows for an amount up to PLN100.3 million ($27.4 million) and will bear interest at the one month Warsaw Interbank Offered Rate ("WIBOR") plus 1.0% per annum, unless the Company’s funded debt to Earnings before Interest, Taxes and Depreciation ratio exceeds 3.0 to 1, at which point the WIBOR spread becomes 1.5%. The loan agreement also contains, among other provisions, requirements for maintaining levels of net worth and profitability. The maturity date of the loan is January 31, 2035 and is payable in annual installments in the amounts of PLN5.3 million ($1.5 million) in 2026, PLN9.0 million ($2.5 million) in 2027, PLN9.6 million ($2.6 million) in 2028 through 2034, and PLN18.8 million ($5.2 million) in 2035.
The foregoing summary of the terms of the loan does not purport to be complete and is qualified in its entirety by reference to full text of the Investment Loan Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 2.03.

Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No.Description
10.1
Investment Loan Agreement, dated July 16, 2025, between PLP Poland (Belos) S.A. and Bank Pekao S.A., filed herewith (English translation).
104Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PREFORMED LINE PRODUCTS COMPANY
Date:
July 22, 2025
By: /s/ Caroline S. Vaccariello
Caroline S. Vaccariello, General Counsel & Corporate Secretary

Preformed Line

NASDAQ:PLPC

PLPC Rankings

PLPC Latest News

PLPC Latest SEC Filings

PLPC Stock Data

795.88M
2.54M
50.47%
42.52%
1.22%
Electrical Equipment & Parts
Water, Sewer, Pipeline, Comm & Power Line Construction
Link
United States
CLEVELAND